Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells

International Journal of Cancer

Volumn 85, Issue 2, 2000, Pages 275-280

  Usuda, Jitsuo ^a,c   Saijo, Nagahiro ^a,b   Fukuoka, Kazuya ^a   Fukumoto, Hisao ^a   Kuh, Hyo Jeong ^a   Nakamura, Takashi ^a   Koh, Yasuhiro ^a   Suzuki, Toshihiro ^a   Koizumi, Fumiaki ^a   Tamura, Tomohide ^b   Kato, Harubumi ^c   Nishio, Kazuto ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; CYCLIN DEPENDENT KINASE; INTERFERON REGULATORY FACTOR 1; ISOENZYME; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0034650911     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000115)85:2<275::AID-IJC20>3.0.CO;2-5     Document Type: Article

References (15)

1. AKINAGA, S., GOMI, K., MORIMOTO, M., TAMAOKI, T. and OKABE, M., Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res., 51, 4888-4892 (1991).
2. AKINAGA, S., NOMURA, K., GOMI, K. and OKABE, M., Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell cycle distribution of human epidermoid carcinoma A431 cells. Cancer Chemother. Pharmacol., 33, 273-280 (1994).
3. Cip1/WAF1/Sdi1 in p53-mutated human epidemoid carcinoma A431 cells. Cancer Res., 57, 1495-1501 (1997).
4. COURAGE, C., BRADDER, S.M., JONES, T., SCHULTZE-MOSGAU, M.H. and GESCHER, A., Characterisation of novel lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. Int. J. Cancer, 73, 763-768 (1997).
5. FUSE, E., and 16 OTHERS, Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human α1 acid glycoprotein. Cancer Res., 58, 3248-3253 (1998).
6. KAWAKAMI, K., FUTAMI, H., TAKAHARA, J. and YAMAGUCHI, K., UCN-01, 7-hydroxylstaurosporine, inhibits kinase activity of cyclin-dependent kinase and reduces the phosphorylation of the retinoblastoma susceptibility gene product in an A549 human lung carcinoma cell line. Biochem. biophys. Res. Comm., 219, 778-783 (1996).
7. LUSH, R., SENDEROWICZ, A.M., FIGG, W.D., HEADLEE, D., INOUE, K. and SAUSVILLE, E.A., Surprising pharmacokinetics of UCN-01 in patients with refractory neoplasms may be due to high degree of protein binding. Proc. Amer. Assoc. Cancer Res., 38, 4029 (1997).
8. MOSMANN, T., Rapid calorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays. J. immunol. Meth., 65, 55 (1983).
9. POLLACK, I.F., KAWECKI, S. and LAZO, J.S., Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase inhibitor. J. Neurosurg., 84, 1024-1032 (1996).
10. SEYNAEVE, C.M., KAZANIETZ, M.G., BLUMBERG, P. M., SAUSVILLE, E.A. and WORLAND, P. J., Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol., 45, 1207-1214 (1994).
11. SEYNAEVE, C.M., STETLER-STEVENSON, M., KAUR, G., SAUAVILLE, E.A. and WORLAND, P. J., Cell cycle arrest and inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res., 53, 2081-2086 (1993).
12. TAKAHASHI, I., KOBAYASHI, E., NAKANO, H., MURAKATA, C., SAITOH, H., SUZUKI, K. and TAMAOKI, T., Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C. J. Pharmacol exp Ther., 255, 1218-1221 (1990).
13. TAKIGAWA, N., OHNOSHI, T., UEOKA, H., KIURA, K. and KIMURA, I., Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. Acta med. Okayama, 46, 203-212 (1992).
14. TANAKA, N., ISHIHARA, M., LAMPHIER, M.S., NOZAWA, H., MATSUYAMA, T., MAK, T.W., AIZAWA, S., TORINO, T., OREN, M. and TANIGUCHI, T., Cooperation of the tumor suppressors IRF-1 and p53 in respose to DNA damage. Nature, 382, 816-818 (1996).
15. WANG, Q., WORLAND, P.J., CLARK, J.L., CARLSON, B.A. and SAUSVILLE, E.A., Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinase 1 and 2. Cell Growth Differentiation, 6, 927-936 (1995).